BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
6.93
+0.30 (4.52%)
At close: Oct 20, 2025, 4:00 PM EDT
6.90
-0.03 (-0.42%)
After-hours: Oct 20, 2025, 7:50 PM EDT

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $163.35M in the quarter ending June 30, 2025, with 49.41% growth. This brings the company's revenue in the last twelve months to $557.51M, up 45.85% year-over-year. In the year 2024, BioCryst Pharmaceuticals had annual revenue of $450.71M with 36.00% growth.

Revenue (ttm)
$557.51M
Revenue Growth
+45.85%
P/S Ratio
2.48
Revenue / Employee
$961,217
Employees
580
Market Cap
1.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024450.71M119.30M36.00%
Dec 31, 2023331.41M60.59M22.37%
Dec 31, 2022270.83M113.66M72.31%
Dec 31, 2021157.17M139.36M782.38%
Dec 31, 202017.81M-31.02M-63.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro